MedPath

Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department

Conditions
Covid19
SARS-CoV Infection
Registration Number
NCT04779021
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Brief Summary

The main objective of this cohort is to characterize COVID-19 patients hospitalized in infectious disease department. The collection of clinical and biological data from start of hospitalization to long-term follow up will contribute to a better description of the patient care, to the identification of predisposition to complication related to the disease, and to the evaluation of the impact of different therapeutical strategies.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1300
Inclusion Criteria
  • Age > or = to 18
  • Patients hospitalised for SARS-CoV-2 infection confirmed by RT PCRand/or CT scan and/or serology
Exclusion Criteria
  • Patients for whom SARS-CoV-2 infection has not been confirmed

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical characteristics34 months

Describe the clinical characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity

Biological characteristics34 months

Describe the biological characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity

Radiological characteristics34 months

Describe the radiological characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity

Secondary Outcome Measures
NameTimeMethod
ICU Length of Stay (LOS)34 months

Duration measured in days

Overall Inpatient Mortality34 months

Number of death due to Covid-19

Requirement for mechanical ventilation34 months

Number of patients requiring mechanical ventilation

Evolution of patient general state during hospitalisation34 months

the different measures (Body Mass Index (BMI), respiratory rate at rest, peripheral oxygen saturation, need for oxygen supplementation, body temperature) will be aggregated in order to obtain a clinical status corresponding to the clinical evolution (good or bad) of the patient's general state.

Biological tests34 months

Dosage of Lymphocytes, C-reactive protein and IL-6

Number of patient hospitalised for Covid-1934 months

Inpatient up to Day 28 or discharge

Trial Locations

Locations (2)

CHU de NICE - Urgences

馃嚝馃嚪

Nice, France

CHU de NICE - Infectiologie

馃嚝馃嚪

Nice, France

漏 Copyright 2025. All Rights Reserved by MedPath